SEP 19, 2015 05:55 PM PDT

Two Genes Could Help with Treatment of Schizophrenia

The abnormal behavior of two genes (BDNF and DTNBP1) is related to the underlying cause of schizophrenia, providing a new target for schizophrenia treatment, according to research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS). The study was published online in the journal Biological Psychiatry and reported in Drug Discovery & Development
Abnormal behavior of two genes causes schizophrenia. 
Schizophrenia, a devastating mental disorder, affects nearly 1 percent of the total human population. The primary cause of the disorder involves impaired brain development that eventually leads to imbalanced signals in the brain. This imbalance may cause hallucinations and paranoia in people with schizophrenia.
 
As senior author Assistant Professor Shawn Je, from the Neuroscience and Behavioral Disorders Programme at Duke-NUS, explained, "We wanted to understand the mechanism by which the brain circuit operates. In particular, we wanted to understand the ability of a specific type of cell in the brain, termed interneurons, to modulate brain network activity to maintain a balance in brain signalling."
 
Dr. Je and his team analyzed signaling activity in neuronal cultures that either did not have the DTNBP1 gene or had lowered levels of the gene. They found that reduced DTNBP1 levels and genetic disruptions of DTNBP1 in mice resulted in schizophrenia-like behaviors. When using multiple model systems, they discovered that the low levels of DTNBP1 caused dysfunctional interneurons and over-activated neuronal network activity. Lowering levels of DTNBP1 also reduced the levels of the secreted protein molecule, BDNF.
 
The researchers showed that BDNF was one of the most important factors that regulate the development of a normal brain circuit. BDNF plays an important role in the interneurons’ ability to connect to the brain. Interneurons receive BDNF via a transport system controlled by DTNBP1. Think of the process as the delivery of a parcel: DTNBP1 acts as the driver of the delivery van. Without the driver, the parcel BDNF cannot be delivered to the required destination. If BDNF is lacking, there is abnormal circuit development and brain network activity observed in schizophrenia patients. Dr. Je and his team also found that when BDNF levels were restored, brain development and activity were rescued and returned to more normal levels, despite the absence of DTNBP1.
 
DTNBP1 and BDNF have been singled out as risk genes for schizophrenia in studies before, but this is the first study to demonstrate that the two work together. Highlighting the importance of the abnormal delivery of BDNF has offered much insight into how the brain network develops. The study also offers possibilities for new treatments for schizophrenia based on enhancing BDNF levels.
 
Dr. Je plans to do a follow-up study to determine whether these findings are viable in an animal model. If he and his colleagues are successful, it could mean that changing the imbalance in the brain circuits of schizophrenia patients could bring us closer to developing a treatment.
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 05, 2018
Health & Medicine
SEP 05, 2018
Can AI Algorithms Accurately Assess Mental Illness?
Mental illness is complicated because while the causes are rooted in brain chemistry, neurological injury or other mechanisms in the brain, what is most af...
SEP 26, 2018
Neuroscience
SEP 26, 2018
Is Learning to Lie a Childhood Milestone?
Parents have all sorts of worries when it comes to bringing up their children. They want the best nutrition, the safest products, and activities and experi...
OCT 04, 2018
Neuroscience
OCT 04, 2018
Breast Milk is Brain Food for Preemies
A due date for a baby represents great hope to parents and families. Any due date is an educated guess, and some babies arrive a little early or a little l...
OCT 18, 2018
Cannabis Sciences
OCT 18, 2018
This is Your Brain on Weed
Here is a first: a marijuana          https://youtu.be/_DlFcMWdsxw...
OCT 22, 2018
Neuroscience
OCT 22, 2018
Brain encodes food preference decisions
Expanding ventral pallidum, a basal ganglia structures role in reward-related decision making....
NOV 01, 2018
Cell & Molecular Biology
NOV 01, 2018
Researchers Link Parkinson's Disease and the Appendix
When a person's appendix is removed early in life, it reduces their chances of getting Parkinson's disease....
Loading Comments...